$EDSA
Edesa Biotech, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Toronto
EDSA chart
What traders are saying about $EDSA
Latest postsEdesa Biotech, Inc. news
- Edesa Biotech Surges After Japan Licensing Deal for Paridiprubart
Quiver Quantitative ·
- Biotech Stock Edesa Biotech, Inc. (Nasdaq: EDSA) Surges on Japanese Deal
Investorideas.com ·
- 12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga ·
- BC-Most Active Stocks
Yahoo Finance ·
- $Edesa Biotech (EDSA.US)$ consolidating on our major timeframe fast we seen this before
Moomoo ·
- Edesa Biotech Grants Kyorin Japanese Rights to Paridiprubart
TipRanks ·
- Edesa Biotech Signs Japan Licensing Agreement With Kyorin for Paridiprubart Worth Up to $146 Million
investorshub.advfn.com ·
- Edesa Biotech (EDSA) Partners with KYORIN Pharmaceutical for Par
GuruFocus ·
- Form 8K EDESA BIOTECH For: 9 November By Investing.com
Investing.com Canada ·
- Edesa Biotech licenses ARDS drug to Kyorin for Japan market By Investing.com
Investing.com Canada ·
- Edesa Biotech Announces Agreement with KYORIN Pharmaceutical to Develop and Commercialize Paridiprubart in Japan
Yahoo Finance ·
- Edesa Biotech Announces Agreement with KYORIN
GlobeNewswire ·
Edesa Biotech, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$7.2M | -$6.2M | -$8.4M | -$17.5M |
| Diluted EPS | – | – | – | – |
| Total assets (year end) | $14.7M | $4.2M | $7.8M | $11.7M |
| Cash and equivalents (year end) | $12.1M | $1.6M | – | $8.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Edesa Biotech, Inc.
- Ticker
- EDSA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Toronto
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- September 30
- SEC CIK
- 1540159
- Former names
- Stellar Biotechnologies, Inc.
Frequently asked questions
What exchange is Edesa Biotech, Inc. listed on?
Edesa Biotech, Inc. trades on the Nasdaq under the ticker symbol EDSA.
What industry is Edesa Biotech, Inc. in?
Edesa Biotech, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Edesa Biotech, Inc. headquartered?
Edesa Biotech, Inc.'s business address on file with the SEC is in Toronto.
When does Edesa Biotech, Inc.'s fiscal year end?
Edesa Biotech, Inc.'s fiscal year ends on September 30.
How much revenue did Edesa Biotech, Inc. report?
Edesa Biotech, Inc. reported $0 in revenue for calendar year 2021, according to its SEC filings.